Psychedelics Gain More Traction as New Research Aims to Address Chronic Pain and Mental Illness

Decades later, new research indicates the medical potential of psilocybin and psychedelics in the treatment of chronic pain and mental illness, which affect approximately 20.4% and 20.6% of the adult population respectively.